Can a pill make cancer radiation more effective? new trial aims to find out.
NCT ID NCT05178693
First seen Nov 25, 2025 · Last updated May 18, 2026 · Updated 22 times
Summary
This early-stage trial tests whether giving an oral drug (ASTX727) before standard Lutathera treatment can help the radiation reach more cancer cells in people with metastatic neuroendocrine tumors. About 27 adults will take ASTX727 for 5 days, then receive Lutathera on day 8. The study uses special PET scans to see if the drug reactivates a receptor that Lutathera targets. The goal is to improve treatment response and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hammersmith Hospital
RECRUITINGLondon, London, City of, W12 0HS, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.